Skip to main content
Fig. 3 | BMC Infectious Diseases

Fig. 3

From: Co-infection with hepatitis B virus among tuberculosis patients is associated with poor outcomes during anti-tuberculosis treatment

Fig. 3

HBV DNA profiles in the TB-HBV group. a HBV DNA changes before and after anti-TB treatment. B1, B2, B3 and B4 (solid line) were patients with better clinical outcomes. P1 (dot line) indicated the patient who underwent a sharp increase in HBV DNA from 2.00 log to 5.13 log and subsequently died; b HBV DNA levels after the onset of liver injury and admission to our hospital in different outcome subgroups (Median [log10 IU/ml]: 5.55 vs. 4.24, P = 0.156)

Back to article page
\